03:45 AM EST, 11/14/2025 (MT Newswires) -- Jon Congleton, Director, Chief Executive Officer, on November 11, 2025, sold 200,000 shares in Mineralys Therapeutics ( MLYS ) for $9,088,499. Following the Form 4 filing with the SEC, Congleton has control over a total of 631,305 common shares of the company, with 631,305 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000193341425000151/xslF345X05/wk-form4_1763078487.xml